[Fertility preservation in transgender people].
Préservation de la fertilité chez les personnes transgenres.
Journal
Medecine sciences : M/S
ISSN: 1958-5381
Titre abrégé: Med Sci (Paris)
Pays: France
ID NLM: 8710980
Informations de publication
Date de publication:
Nov 2022
Nov 2022
Historique:
entrez:
30
11
2022
pubmed:
1
12
2022
medline:
3
12
2022
Statut:
ppublish
Résumé
Most of transgender people plan to have a family but their fertility may be affected by gender affirmation. Hormone therapy can permanently affect gamete production, especially in trans women. Sex reassignment surgery leads to permanent sterility. In France, networks of health professionals have been organized and recommend access to fertility preservation for trans people. However, gamete collection is often difficult due to hormonal incongruence for trans women or to the invasive nature of the procedure for trans men. Future studies are required to assess the use of self-preserved gametes by trans people. Préservation de la fertilité chez les personnes transgenres. La majorité des personnes transgenres envisage de fonder une famille, mais leur fertilité peut être altérée par l’affirmation du genre. L’hormonothérapie peut affecter durablement la production de gamètes, notamment chez les femmes trans. La chirurgie de réassignation sexuelle entraîne une stérilité définitive. En France, des réseaux de professionnels de santé se sont organisés. Ils recommandent l’accès à la préservation de la fertilité dans le cadre de la transidentité. Cependant, le recueil de gamètes reste souvent difficile en raison de l’incongruence hormonale pour les femmes trans, ou du caractère invasif de la procédure pour les hommes trans. De futures études permettront de statuer sur l’utilisation des gamètes autoconservés.
Autres résumés
Type: Publisher
(fre)
Préservation de la fertilité chez les personnes transgenres.
Identifiants
pubmed: 36448900
doi: 10.1051/medsci/2022154
pii: msc220227
doi:
Types de publication
English Abstract
Journal Article
Langues
fre
Sous-ensembles de citation
IM
Pagination
926-933Informations de copyright
© 2022 médecine/sciences – Inserm.
Références
World Professional Association for Transgender Health. Standards of Care for the Health of Transsexual, Transgender, and Gender Nonconforming People [7th Version]. 2012.
Zucker KJ. Gender identity development and issues. Child Adolesc Psychiatr Clin N Am 2004 ; 13 : 551–568.
Baram S, Myers SA, Yee S, et al. Fertility preservation for transgender adolescents and young adults: A systematic review. Hum Reprod Update 2019 ; 25 : 694–716.
Wierckx K, Van Caenegem E, Pennings G, et al. Reproductive wish in transsexual men. Hum Reprod Oxf Engl 2012 ; 27 : 483–487.
Chiniara LN, Viner C, Palmert M, et al. Perspectives on fertility preservation and parenthood among transgender youth and their parents. Arch Dis Child 2019 ; 104 : 739–744.
Auer MK, Fuss J, Nieder TO, et al. Desire to Have Children Among Transgender People in Germany: A Cross-Sectional Multi-Center Study. J Sex Med 2018 ; 15 : 757–767.
Chen D, Simons L, Johnson EK, et al. Fertility Preservation for Transgender Adolescents. J Adolesc Health Off Publ Soc Adolesc Med 2017 ; 61 : 120–123.
Nahata L, Tishelman AC, Caltabellotta NM, et al. Low Fertility Preservation Utilization Among Transgender Youth. J Adolesc Health Off Publ Soc Adolesc Med 2017 ; 61 : 40–44.
Ethics Committee of the American Society for Reproductive Medicine. Access to fertility services by transgender and nonbinary persons : an Ethics Committee opinion. Fertil Steril 2021; 115 : 874–8.
https://www.legifrance.gouv.fr/loda/id/JORFTEXT000024323102/.
Eustache F, Drouineaud V, Mendes N, et al. Fertility preservation and sperm donation in transgender individuals: The current situation within the French CECOS network. Androl 2021; 9 : 1790–8.
de Nie I, Mulder CL, Meißner A, et al. Histological study on the influence of puberty suppression and hormonal treatment on developing germ cells in transgender women. Hum Reprod 2022; 37 : 297–308.
Adeleye AJ, Reid G, Kao C-N, et al. Semen Parameters Among Transgender Women With a History of Hormonal Treatment. Urol 2019 ; 124 : 136–141.
Rodriguez-Wallberg KA, Häljestig J, et al. Sperm quality in transgender women before or after gender affirming hormone therapy—A prospective cohort study. Androl 2021; 9 : 1773–80.
Hembree WC, Cohen-Kettenis PT, Gooren L, et al. Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2017 ; 102 : 3869–3903.
Yaish I, Tordjman K, Amir H, et al. Functional ovarian reserve in transgender men receiving testosterone therapy: Evidence for preserved anti-Müllerian hormone and antral follicle count under prolonged treatment. Hum Reprod 2021; 36 : 2753–60.
Grynberg M, Fanchin R, Dubost G, et al. Histology of genital tract and breast tissue after long-term testosterone administration in a female-to-male transsexual population. Reprod Biomed Online 2010 ; 20 : 553–558.
Lierman S, Tilleman K, Braeckmans K, et al. Fertility preservation for trans men : frozen-thawed in vitro matured oocytes collected at the time of ovarian tissue processing exhibit normal meiotic spindles. J Assist Reprod Genet 2017 ; 34 : 1449–1456.
Perrone AM, Cerpolini S, Maria Salfi NC, et al. Effect of Long-Term Testosterone Administration on the Endometrium of Female-to-Male (FtM) Transsexuals. J Sex Med 2009 ; 6 : 3193–3200.
Light AD, Obedin-Maliver J, Sevelius JM, et al. Transgender Men Who Experienced Pregnancy After Female-to-Male Gender Transitioning. Obstet Gynecol 2014 ; 124 : 1120–1127.
Greenwald P, Dubois B, Lekovich J, et al. Successful In Vitro Fertilization in a Cisgender Female Carrier Using Oocytes Retrieved From a Transgender Man Maintained on Testosterone. AACE Clin Case Rep 2022; 8 : 19–21.
Hamada A, Kingsberg S, Wierckx K, et al. Semen characteristics of transwomen referred for sperm banking before sex transition: A case series. Androl 2015 ; 47 : 832–838.
Keros V, Hultenby K, Borgström B, et al. Methods of cryopreservation of testicular tissue with viable spermatogonia in pre-pubertal boys undergoing gonadotoxic cancer treatment. Hum Reprod 2007 ; 22 : 1384–1395.
Rives N, Milazzo J-P, Travers A, et al. Cryopréservation du tissu testiculaire chez l’enfant. Bull Académie Natl Médecine 2013 ; 197 : 877–886.
Grynberg M, Hesters L, Bénard J, et al. Préservation de la fertilité féminine : place de la maturation ovocytaire in vitro. J Gynécologie Obstétrique Biol Reprod 2011 ; 40 : 103–108.
De Roo C, Lierman S, Tilleman K, et al. Ovarian tissue cryopreservation in female-to-male transgender people: Insights into ovarian histology and physiology after prolonged androgen treatment. Reprod Biomed Online 2017 ; 34 : 557–566.
Dolmans M-M, Falcone T, Patrizio P. Importance of patient selection to analyze in vitro fertilization outcome with transplanted cryopreserved ovarian tissue. Fertil Steril 2020; 114 : 279–80.
Alpern S, Yaish I, Wagner-Kolasko G, et al. Why fertility preservation rates of transgender men are much lower than those of transgender women. Reprod Biomed Online 2022; 44 : 943–50.
Quain KM, Kyweluk MA, Sajwani A, et al. Timing and Delivery of Fertility Preservation Information to Transgender Adolescents, Young Adults, and Their Parents. J Adolesc Health 2021; 68 : 619–22.
Lu CC, Steinberger A. Effects of estrogen on human seminiferous tubules : Light and electron microscopic analysis. Am J Anat 1978 ; 153 : 1–13.
Payer AF, Meyer WJ, Walker PA. The Ultrastructural Response of Human Leydig Cells to Exogenous Estrogens. Androl 2009 ; 11 : 423–436.
Thiagaraj D, Gunasegaram R, Loganath A, et al. Histopathology of the testes from male transsexuals on oestrogen therapy. Ann Acad Med Singapore 1987 ; 16 : 347–348.
Venizelos ID, Paradinas FJTesticular atrophy after oestrogen therapy. Histopathol 1988 ; 12 : 451–454.
Sapino A, Pagani A, Godano A, et al. Effects of estrogens on the testis of transsexuals : a pathological and immunocytochemical study. Virchows Arch A Pathol Anat Histopathol 1987 ; 411 : 409–414.
Schulze C.. Response of the human testis to long-term estrogen treatment: Morphology of Sertoli cells, Leydig cells and spermatogonial stem cells. Cell Tissue Res 1988 ; 251 : 31–43.
Schneider F, Neuhaus N, Wistuba J, et al. Testicular Functions and Clinical Characterization of Patients with Gender Dysphoria (GD) Undergoing Sex Reassignment Surgery (SRS). J Sex Med 2015 ; 12 : 2190–2200.
Kent MA, Winoker JS, Grotas AB. Effects of Feminizing Hormones on Sperm Production and Malignant Changes: Microscopic Examination of Post Orchiectomy Specimens in Transwomen. Urol 2018 ; 121 : 93–96.
Jindarak S, Nilprapha K, Atikankul T, et al. Spermatogenesis Abnormalities following Hormonal Therapy in Transwomen. BioMed Res Int 2018 ; 2018 : 1–5.
Jiang DD, Swenson E, Mason M, et al. Effects of Estrogen on Spermatogenesis in Transgender Women. Urol 2019 ; 132 : 117–122.
Vereecke G, Defreyne J, Van Saen D, et al. Characterisation of testicular function and spermatogenesis in transgender women. Hum Reprod 2020 : deaa254.
Peri A, Ahler A, Gook D, et al. Predicting successful sperm retrieval in transfeminine adolescents after testicular biopsy. J Assist Reprod Genet 2021; 38 : 2735–43.
Cho K, Harjee R, Roberts J, et al. Fertility preservation in a transgender man without prolonged discontinuation of testosterone: A case report and literature review. FS Rep 2020; 1 : 43–7.
Amir H, Oren A, Klochendler Frishman E, et al. Oocyte retrieval outcomes among adolescent transgender males. J Assist Reprod Genet 2020; 37 : 1737–44.
Gale J, Magee B, Forsyth-Greig A, et al. Oocyte cryopreservation in a transgender man on long-term testosterone therapy: A case report. FS Rep 2021; 2 : 249–51.
Barrett J. Fertility preservation for transgender individuals. Reprod Fertil 2022; 3 : C11–3.
Stark BA, Mok-Lin E. Fertility preservation in transgender men without discontinuation of testosterone. FS Rep 2022; 3 : 153–6.